http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Ontra Earns Prestigious 2025 Great Place To Work Certification™
-
Neurocrine Biosciences Announces Publication on Traditional Glucocorticoid Treatment in Classic Congenital Adrenal Hyperplasia in Expert Review of Endocrinology & Metabolism
-
Foresight Diagnostics Provides 2025 Outlook and 2024 Year in Review
-
Mother's® Cookies Introduces First-Ever Chocolatey Flavor - Dynamite Dinosaurs - Inspired by 'Jurassic World'
-
Safety Shot to Acquire Yerbaé Brands Corp., adding approximately $12 Million to Annual Revenue and Creating a Potential Force in Wellness and Functional Beverages
-
Ondas Receives Order from Major Defense Company for Integration of New Applications to its AI-Driven Iron Drone Raider System
-
Blackstone Mortgage Trust Announces Fourth-Quarter and Full-Year 2024 Earnings Release and Conference Call
-
Turning Bottles into Blockchain: SuperWine Revolutionizes Fine Wine Investment with Web3
-
Toshiba Continues Commitment to Retail Innovation with New Flexible and Cutting-Edge Solutions at NRF 2025
-
QDOBA Kicks Off 2025 with Planned New Franchise Development Agreements across the U.S.
-
Mineralys Therapeutics (MLYS) Announces Phase 2 Clinical Trial of Lorundrostat for Obstructive Sleep Apnea in Patients with Hypertension
-
TriSalus Life Sciences (TLSI) Announces Leadership Changes
-
Champions Oncology (CSBR) Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership
-
NV5 Global (NVEE) Announces New Goal of $1.6 Billion in Revenues by 2028
-
Bitdeer Announces December 2024 Production and Operations Update
-
Halia Therapeutics to Attend the 43rd J.P. Morgan Healthcare Conference and Present at BioPharma Obesity Innovation Forum in San Francisco
-
Cellebrite Announces Participation in the 27th Annual Needham & Company Growth Conference
-
Longsys Debuts First NFC PSSD at CES 2025, Drawing Industry Attention
-
Gameto to Present at 43rd Annual J.P. Morgan Healthcare Conference
-
CrowdStrike Achieves FedRAMP Authorization for New Modules to Secure Highly Regulated Industries in the Cloud
-
Mineralys Therapeutics Announces Phase 2 Clinical Trial of Lorundrostat for Obstructive Sleep Apnea in Patients with Hypertension
-
January 2025 Update Letter to Shareholders
-
Cogent Biosciences Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
-
Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership
-
Cellebrite Announces Participation in the 27th Annual Needham & Company Growth Conference
-
Palvella Therapeutics Announces First Patients Dosed in Phase 2 TOIVA Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Cutaneous Venous Malformations
-
NV5 Announces New Goal of $1.6 Billion in Revenues by 2028
-
BitMEX Launches Multi Asset Margining: Simplifying Trading for Derivatives Markets
-
TriSalus Announces Leadership Changes
-
Soluna Announces Monthly Business Update
-
CytomX Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Myeloid Therapeutics to Present at 43rd Annual JP Morgan Healthcare Conference
-
Asher Bio Announces Clinical Trial Collaboration and Supply Agreement on Etakafusp Alfa (AB248) in Combination with Bispecific T-cell Engager in Patients with Small Cell Lung Cancer
-
Grande Portage Resources Initiates Sensor-Based Ore Sorting Testwork
-
Foresight Regains Compliance with Nasdaq Minimum Bid Price Rule
-
Trevi Therapeutics (TRVI) Announces Company Updates Ahead of 14th Annual LifeSci Partners Corporate Access Event Held During the J.P. Morgan Healthcare Conference
-
BridgeBio Pharma to Participate in the J.P. Morgan Healthcare Conference
-
Trevi Therapeutics Announces Company Updates Ahead of 14th Annual LifeSci Partners Corporate Access Event Held During the J.P. Morgan Healthcare Conference
-
Bionoid Pharma, Inc. Reports Over $100,000 in Revenue Following Binding LOI With Your Supplement Supply Store Ltd.
-
UK universities join retreat from Elon Musk's X, citing misinformation on platform
-
South Star Battery Metals Announces Closing of Final Tranche of Upsized Private Placement Raising Gross Proceeds of US$3M
-
Absci Corporation (ABSI) and AMD (AMD) Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery
-
Shutterstock (SSTK) Appoints Matt Furlong as Chief Marketplace Officer
-
Boston Scientific (BSX) to Acquire Bolt Medical
-
BIO-TECHNE TO PRESENT AT PHACILITATE ADVANCED THERAPIES WEEK 2025
-
BioStem Technologies Launches Clinical Trial to Demonstrate the Therapeutic Benefits of its BioREtain® Technology in Treating Diabetic Foot Ulcers Using Vendaje®
-
Shutterstock Appoints Matt Furlong as Chief Marketplace Officer
-
ASDSA Finds Lack of Physician Supervision in Medical Spas
-
Halozyme Reiterates 2024 Financial Guidance and Raises 2025 and Multi-Year Financial Guidance
-
ScaleReady Announces a G-Rex® Grant has been awarded to Seattle Children's Therapeutics


